6-4

 

Bridging the translational research gap between discovery and treatment,

 

71

6-5

 

UC Berkeley IPIRA intellectual property management models,

 

74

BOXES

4-1

 

Examples of Business Models for Funding the Development of Drugs to Treat Rare and Neglected Diseases,

 

20

5-1

 

Examples of Data Sharing Models for Biomedical Research,

 

46

6-1

 

Managing Strategic Alliances, Licensing, and Intellectual Property: Company, Foundation, and University Perspectives,

 

56

6-2

 

Examples of Serendipitous Dual Markets,

 

61

6-3

 

Gates Foundation Global Access Agreements,

 

62

6-4

 

Examples of Innovations Licensed and/or Funded Under the Socially Responsible Licensing Program (SLRP) at UC Berkeley,

 

76

6-5

 

Highlights of “In the Public Interest: Nine Points to Consider in Licensing University Technology,”

 

78

7-1

 

Examples of Disease Foundation Strategies for Facilitating Clinical Trials,

 

84

7-2

 

FDA Review: Opportunities to Facilitate the Drug Development and Approval Processes,

 

86



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement